167 related articles for article (PubMed ID: 30394302)
1. Drug-Drug Interactions Potential of Direct-Acting Antivirals for the treatment of Chronic Hepatitis C Virus infection.
Néant N; Solas C
Int J Antimicrob Agents; 2020 Jul; 56(1):105571. PubMed ID: 30394302
[TBL] [Abstract][Full Text] [Related]
2. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
[TBL] [Abstract][Full Text] [Related]
3. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
4. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
Rodríguez-Torres M
Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents.
Murray M
Clin Pharmacokinet; 2023 Oct; 62(10):1365-1392. PubMed ID: 37731164
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
7. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
[TBL] [Abstract][Full Text] [Related]
8. Drug-drug interactions between direct-acting antivirals and co-medications: a territory-wide cohort study.
Hui VW; Au CL; Lam ASM; Yip TC; Tse YK; Lai JC; Chan HL; Wong VW; Wong GL
Hepatol Int; 2022 Dec; 16(6):1318-1329. PubMed ID: 36074319
[TBL] [Abstract][Full Text] [Related]
9. Key drug-drug interactions with direct-acting antiviral in HIV-HCV coinfection.
El-Sherif O; Khoo S; Solas C
Curr Opin HIV AIDS; 2015 Sep; 10(5):348-54. PubMed ID: 26248122
[TBL] [Abstract][Full Text] [Related]
10. The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection.
Garrison KL; German P; Mogalian E; Mathias A
Drug Metab Dispos; 2018 Aug; 46(8):1212-1225. PubMed ID: 29695614
[TBL] [Abstract][Full Text] [Related]
11. High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
Macías J; Monge P; Mancebo M; Merchante N; Neukam K; Real LM; Pineda JA
HIV Med; 2017 Aug; 18(7):445-451. PubMed ID: 27882706
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".
Pol S; Parlati L
Liver Int; 2018 Feb; 38 Suppl 1():28-33. PubMed ID: 29427485
[TBL] [Abstract][Full Text] [Related]
13. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Rockstroh JK
Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
[TBL] [Abstract][Full Text] [Related]
14. Are there any challenges left in hepatitis C virus therapy of HIV-infected patients?
Bischoff J; Rockstroh JK
Int J Antimicrob Agents; 2020 Jul; 56(1):105527. PubMed ID: 30145247
[TBL] [Abstract][Full Text] [Related]
15. Management of the Patient With HIV/Hepatitis C Drug Interactions: A Guide for Nurses and Nurse Practitioners.
Starbird LE; Hong H; Sulkowski MS; Farley JE
J Assoc Nurses AIDS Care; 2020; 31(2):241-248. PubMed ID: 31855873
[TBL] [Abstract][Full Text] [Related]
16. Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
Poizot-Martin I; Naqvi A; Obry-Roguet V; Valantin MA; Cuzin L; Billaud E; Cheret A; Rey D; Jacomet C; Duvivier C; Pugliese P; Pradat P; Cotte L;
PLoS One; 2015; 10(10):e0141164. PubMed ID: 26488159
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
Chan J; Chung RT
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.
Uriarte-Pinto M; Navarro-Aznarez H; De La Llama-Celis N; Arazo-Garcés P; Martínez-Sapiña AM; Abad-Sazatornil MR
Int J Clin Pharm; 2018 Jun; 40(3):608-616. PubMed ID: 29556931
[TBL] [Abstract][Full Text] [Related]
19. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
[TBL] [Abstract][Full Text] [Related]
20. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
